These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31433545)

  • 21. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
    Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
    Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
    Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
    Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Prevalence and Clinical Relevance of Nonexpandable Lung in Malignant Pleural Mesothelioma. A Prospective, Single-Center Cohort Study of 229 Patients.
    Bibby AC; Halford P; De Fonseka D; Morley AJ; Smith S; Maskell NA
    Ann Am Thorac Soc; 2019 Oct; 16(10):1273-1279. PubMed ID: 31189069
    [No Abstract]   [Full Text] [Related]  

  • 24. Outcomes of bevacizumab combined with chemotherapy in lung adenocarcinoma-induced malignant pleural effusion.
    Tao H; Meng Q; Li M; Shi L; Tang J; Liu Z
    Thorac Cancer; 2018 Feb; 9(2):298-304. PubMed ID: 29297985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study.
    Walsh SLF; Wells AU; Desai SR; Poletti V; Piciucchi S; Dubini A; Nunes H; Valeyre D; Brillet PY; Kambouchner M; Morais A; Pereira JM; Moura CS; Grutters JC; van den Heuvel DA; van Es HW; van Oosterhout MF; Seldenrijk CA; Bendstrup E; Rasmussen F; Madsen LB; Gooptu B; Pomplun S; Taniguchi H; Fukuoka J; Johkoh T; Nicholson AG; Sayer C; Edmunds L; Jacob J; Kokosi MA; Myers JL; Flaherty KR; Hansell DM
    Lancet Respir Med; 2016 Jul; 4(7):557-565. PubMed ID: 27180021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indwelling Pleural Catheters: A Clinical Option in Trapped Lung.
    Bertolaccini L; Viti A; Paiano S; Pomari C; Assante LR; Terzi A
    Thorac Surg Clin; 2017 Feb; 27(1):47-55. PubMed ID: 27865327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control.
    Qian Q; Zhan P; Sun WK; Zhang Y; Song Y; Yu LK
    Neoplasma; 2012; 59(4):433-9. PubMed ID: 22489699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of minimal pleural effusion in non-small-cell lung cancer.
    Ryu JS; Ryu HJ; Lee SN; Memon A; Lee SK; Nam HS; Kim HJ; Lee KH; Cho JH; Hwang SS
    J Clin Oncol; 2014 Mar; 32(9):960-7. PubMed ID: 24550423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary tumour resection in non-small-cell lung cancer patients with ipsilateral pleural dissemination (M1a): a population-based study.
    Li H; Sun Z; Yang F; Sui X; Liu T; Wang J
    Eur J Cardiothorac Surg; 2019 Jun; 55(6):1121-1129. PubMed ID: 30726889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score.
    Clive AO; Kahan BC; Hooper CE; Bhatnagar R; Morley AJ; Zahan-Evans N; Bintcliffe OJ; Boshuizen RC; Fysh ET; Tobin CL; Medford AR; Harvey JE; van den Heuvel MM; Lee YC; Maskell NA
    Thorax; 2014 Dec; 69(12):1098-104. PubMed ID: 25100651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of Prognostic Factors and Clinical Characteristics for Patients with Limited Stage Small Cell Lung Cancer with Pleural Effusion].
    Xu K; Wang Y; Qi J; Zhao L; Wang P
    Zhongguo Fei Ai Za Zhi; 2018 Jan; 21(1):16-23. PubMed ID: 29357968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Factors of 30-Day Mortality After Palliative Procedures in Patients with Malignant Pleural Effusion.
    Abrao FC; de Abreu IR; Fogarolli M; Caxeiro G; Bezerra CB; de Cerqueira Cesar FP; Rocha PS; Younes RN
    Ann Surg Oncol; 2015 Nov; 22(12):4083-8. PubMed ID: 25758190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients.
    Lee YS; Nam HS; Lim JH; Kim JS; Moon Y; Cho JH; Ryu JS; Kwak SM; Lee HL
    BMC Cancer; 2017 Aug; 17(1):557. PubMed ID: 28830378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis of Cancer with Synchronous or Metachronous Malignant Pleural Effusion.
    Porcel JM; Solé C; Salud A; Bielsa S
    Lung; 2017 Dec; 195(6):775-779. PubMed ID: 28900718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal Pleural Effusion in Small Cell Lung Cancer: Proportion, Mechanisms, and Prognostic Effect.
    Ryu JS; Lim JH; Lee JM; Kim WC; Lee KH; Memon A; Lee SK; Yi BR; Kim HJ; Hwang SS
    Radiology; 2016 Feb; 278(2):593-600. PubMed ID: 26323029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thoracoscopic talc pleurodesis for malignant pleural effusion.
    Love D; White D; Kiroff G
    ANZ J Surg; 2003; 73(1-2):19-22. PubMed ID: 12534732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion.
    Lim JU; Yeo CD; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Lee SH
    PLoS One; 2018; 13(7):e0200341. PubMed ID: 30005083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis].
    Chella A; Ribechini A; Dini P; Adamo C; Mussi A; Angeletti CA
    Minerva Chir; 1994 Nov; 49(11):1077-82. PubMed ID: 7708227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unexpandable lung from pleural disease.
    Huggins JT; Maldonado F; Chopra A; Rahman N; Light R
    Respirology; 2018 Feb; 23(2):160-167. PubMed ID: 29064169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Observational Study Evaluating the Performance of LENT Score in the Selected Population of Malignant Pleural Effusion from Lung Adenocarcinoma in Singapore.
    Abisheganaden J; Verma A; Dagaonkar RS; Light RW
    Respiration; 2018; 96(4):308-313. PubMed ID: 29945142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.